IBDEI200 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,31886,1,4,0)
;;=4^N30.10
;;^UTILITY(U,$J,358.3,31886,2)
;;=^5015634
;;^UTILITY(U,$J,358.3,31887,0)
;;=N30.90^^126^1634^13
;;^UTILITY(U,$J,358.3,31887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31887,1,3,0)
;;=3^Cystitis w/o Hematuria,Unspec
;;^UTILITY(U,$J,358.3,31887,1,4,0)
;;=4^N30.90
;;^UTILITY(U,$J,358.3,31887,2)
;;=^5015642
;;^UTILITY(U,$J,358.3,31888,0)
;;=N30.91^^126^1634^12
;;^UTILITY(U,$J,358.3,31888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31888,1,3,0)
;;=3^Cystitis w/ Hematuria,Unspec
;;^UTILITY(U,$J,358.3,31888,1,4,0)
;;=4^N30.91
;;^UTILITY(U,$J,358.3,31888,2)
;;=^5015643
;;^UTILITY(U,$J,358.3,31889,0)
;;=N81.11^^126^1634^15
;;^UTILITY(U,$J,358.3,31889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31889,1,3,0)
;;=3^Cystocele,Midline
;;^UTILITY(U,$J,358.3,31889,1,4,0)
;;=4^N81.11
;;^UTILITY(U,$J,358.3,31889,2)
;;=^331534
;;^UTILITY(U,$J,358.3,31890,0)
;;=R30.0^^126^1634^16
;;^UTILITY(U,$J,358.3,31890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31890,1,3,0)
;;=3^Dysuria
;;^UTILITY(U,$J,358.3,31890,1,4,0)
;;=4^R30.0
;;^UTILITY(U,$J,358.3,31890,2)
;;=^5019322
;;^UTILITY(U,$J,358.3,31891,0)
;;=N80.1^^126^1634^17
;;^UTILITY(U,$J,358.3,31891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31891,1,3,0)
;;=3^Endometriosis of Ovary
;;^UTILITY(U,$J,358.3,31891,1,4,0)
;;=4^N80.1
;;^UTILITY(U,$J,358.3,31891,2)
;;=^270484
;;^UTILITY(U,$J,358.3,31892,0)
;;=N73.9^^126^1634^18
;;^UTILITY(U,$J,358.3,31892,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31892,1,3,0)
;;=3^Female Pelvic Inflammatory Disease,Unspec
;;^UTILITY(U,$J,358.3,31892,1,4,0)
;;=4^N73.9
;;^UTILITY(U,$J,358.3,31892,2)
;;=^5015820
;;^UTILITY(U,$J,358.3,31893,0)
;;=R35.0^^126^1634^21
;;^UTILITY(U,$J,358.3,31893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31893,1,3,0)
;;=3^Frequency of Micturition
;;^UTILITY(U,$J,358.3,31893,1,4,0)
;;=4^R35.0
;;^UTILITY(U,$J,358.3,31893,2)
;;=^5019334
;;^UTILITY(U,$J,358.3,31894,0)
;;=R39.14^^126^1634^24
;;^UTILITY(U,$J,358.3,31894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31894,1,3,0)
;;=3^Incomplete Voiding
;;^UTILITY(U,$J,358.3,31894,1,4,0)
;;=4^R39.14
;;^UTILITY(U,$J,358.3,31894,2)
;;=^5019344
;;^UTILITY(U,$J,358.3,31895,0)
;;=R31.1^^126^1634^25
;;^UTILITY(U,$J,358.3,31895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31895,1,3,0)
;;=3^Microscopic Hematuria
;;^UTILITY(U,$J,358.3,31895,1,4,0)
;;=4^R31.1
;;^UTILITY(U,$J,358.3,31895,2)
;;=^5019326
;;^UTILITY(U,$J,358.3,31896,0)
;;=N20.0^^126^1634^30
;;^UTILITY(U,$J,358.3,31896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31896,1,3,0)
;;=3^Neprolithiasis
;;^UTILITY(U,$J,358.3,31896,1,4,0)
;;=4^N20.0
;;^UTILITY(U,$J,358.3,31896,2)
;;=^67056
;;^UTILITY(U,$J,358.3,31897,0)
;;=R35.1^^126^1634^31
;;^UTILITY(U,$J,358.3,31897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31897,1,3,0)
;;=3^Nocturia
;;^UTILITY(U,$J,358.3,31897,1,4,0)
;;=4^R35.1
;;^UTILITY(U,$J,358.3,31897,2)
;;=^5019335
;;^UTILITY(U,$J,358.3,31898,0)
;;=N83.8^^126^1634^32
;;^UTILITY(U,$J,358.3,31898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31898,1,3,0)
;;=3^Noninflammatory Disorder of Ovary,Fallop & Broad Ligmt
;;^UTILITY(U,$J,358.3,31898,1,4,0)
;;=4^N83.8
;;^UTILITY(U,$J,358.3,31898,2)
;;=^5015864
;;^UTILITY(U,$J,358.3,31899,0)
;;=N39.8^^126^1634^56
;;^UTILITY(U,$J,358.3,31899,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI200 3788 printed Nov 22, 2024@17:29:17 Page 2
IBDEI200 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,31886,1,4,0)
+2 ;;=4^N30.10
+3 ;;^UTILITY(U,$J,358.3,31886,2)
+4 ;;=^5015634
+5 ;;^UTILITY(U,$J,358.3,31887,0)
+6 ;;=N30.90^^126^1634^13
+7 ;;^UTILITY(U,$J,358.3,31887,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,31887,1,3,0)
+10 ;;=3^Cystitis w/o Hematuria,Unspec
+11 ;;^UTILITY(U,$J,358.3,31887,1,4,0)
+12 ;;=4^N30.90
+13 ;;^UTILITY(U,$J,358.3,31887,2)
+14 ;;=^5015642
+15 ;;^UTILITY(U,$J,358.3,31888,0)
+16 ;;=N30.91^^126^1634^12
+17 ;;^UTILITY(U,$J,358.3,31888,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,31888,1,3,0)
+20 ;;=3^Cystitis w/ Hematuria,Unspec
+21 ;;^UTILITY(U,$J,358.3,31888,1,4,0)
+22 ;;=4^N30.91
+23 ;;^UTILITY(U,$J,358.3,31888,2)
+24 ;;=^5015643
+25 ;;^UTILITY(U,$J,358.3,31889,0)
+26 ;;=N81.11^^126^1634^15
+27 ;;^UTILITY(U,$J,358.3,31889,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,31889,1,3,0)
+30 ;;=3^Cystocele,Midline
+31 ;;^UTILITY(U,$J,358.3,31889,1,4,0)
+32 ;;=4^N81.11
+33 ;;^UTILITY(U,$J,358.3,31889,2)
+34 ;;=^331534
+35 ;;^UTILITY(U,$J,358.3,31890,0)
+36 ;;=R30.0^^126^1634^16
+37 ;;^UTILITY(U,$J,358.3,31890,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,31890,1,3,0)
+40 ;;=3^Dysuria
+41 ;;^UTILITY(U,$J,358.3,31890,1,4,0)
+42 ;;=4^R30.0
+43 ;;^UTILITY(U,$J,358.3,31890,2)
+44 ;;=^5019322
+45 ;;^UTILITY(U,$J,358.3,31891,0)
+46 ;;=N80.1^^126^1634^17
+47 ;;^UTILITY(U,$J,358.3,31891,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,31891,1,3,0)
+50 ;;=3^Endometriosis of Ovary
+51 ;;^UTILITY(U,$J,358.3,31891,1,4,0)
+52 ;;=4^N80.1
+53 ;;^UTILITY(U,$J,358.3,31891,2)
+54 ;;=^270484
+55 ;;^UTILITY(U,$J,358.3,31892,0)
+56 ;;=N73.9^^126^1634^18
+57 ;;^UTILITY(U,$J,358.3,31892,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,31892,1,3,0)
+60 ;;=3^Female Pelvic Inflammatory Disease,Unspec
+61 ;;^UTILITY(U,$J,358.3,31892,1,4,0)
+62 ;;=4^N73.9
+63 ;;^UTILITY(U,$J,358.3,31892,2)
+64 ;;=^5015820
+65 ;;^UTILITY(U,$J,358.3,31893,0)
+66 ;;=R35.0^^126^1634^21
+67 ;;^UTILITY(U,$J,358.3,31893,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,31893,1,3,0)
+70 ;;=3^Frequency of Micturition
+71 ;;^UTILITY(U,$J,358.3,31893,1,4,0)
+72 ;;=4^R35.0
+73 ;;^UTILITY(U,$J,358.3,31893,2)
+74 ;;=^5019334
+75 ;;^UTILITY(U,$J,358.3,31894,0)
+76 ;;=R39.14^^126^1634^24
+77 ;;^UTILITY(U,$J,358.3,31894,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,31894,1,3,0)
+80 ;;=3^Incomplete Voiding
+81 ;;^UTILITY(U,$J,358.3,31894,1,4,0)
+82 ;;=4^R39.14
+83 ;;^UTILITY(U,$J,358.3,31894,2)
+84 ;;=^5019344
+85 ;;^UTILITY(U,$J,358.3,31895,0)
+86 ;;=R31.1^^126^1634^25
+87 ;;^UTILITY(U,$J,358.3,31895,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,31895,1,3,0)
+90 ;;=3^Microscopic Hematuria
+91 ;;^UTILITY(U,$J,358.3,31895,1,4,0)
+92 ;;=4^R31.1
+93 ;;^UTILITY(U,$J,358.3,31895,2)
+94 ;;=^5019326
+95 ;;^UTILITY(U,$J,358.3,31896,0)
+96 ;;=N20.0^^126^1634^30
+97 ;;^UTILITY(U,$J,358.3,31896,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,31896,1,3,0)
+100 ;;=3^Neprolithiasis
+101 ;;^UTILITY(U,$J,358.3,31896,1,4,0)
+102 ;;=4^N20.0
+103 ;;^UTILITY(U,$J,358.3,31896,2)
+104 ;;=^67056
+105 ;;^UTILITY(U,$J,358.3,31897,0)
+106 ;;=R35.1^^126^1634^31
+107 ;;^UTILITY(U,$J,358.3,31897,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,31897,1,3,0)
+110 ;;=3^Nocturia
+111 ;;^UTILITY(U,$J,358.3,31897,1,4,0)
+112 ;;=4^R35.1
+113 ;;^UTILITY(U,$J,358.3,31897,2)
+114 ;;=^5019335
+115 ;;^UTILITY(U,$J,358.3,31898,0)
+116 ;;=N83.8^^126^1634^32
+117 ;;^UTILITY(U,$J,358.3,31898,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,31898,1,3,0)
+120 ;;=3^Noninflammatory Disorder of Ovary,Fallop & Broad Ligmt
+121 ;;^UTILITY(U,$J,358.3,31898,1,4,0)
+122 ;;=4^N83.8
+123 ;;^UTILITY(U,$J,358.3,31898,2)
+124 ;;=^5015864
+125 ;;^UTILITY(U,$J,358.3,31899,0)
+126 ;;=N39.8^^126^1634^56
+127 ;;^UTILITY(U,$J,358.3,31899,1,0)
+128 ;;=^358.31IA^4^2
